IFF announced its plans for accelerated entry into the personalized nutrition sector through a strategic partnership with Salus Optima, a British-based, digitally-enabled personalized nutrition, health and wellness company. The initial focus for the partnership will be metabolic health, including obesity, pre-diabetes, high cholesterol and pre-hypertension, which impacts over 25 percent1 of the adult population globally. Together, the companies are developing an unmatched capability to help consumers understand their unique metabolic response to food, supplements, activity and sleep, accessible via mobile phones and wearables.

By leveraging Salus Optima's core technology with IFF's portfolio of health-enabling ingredients from its Nourish and Health & Biosciences business divisions, brand owners can offer consumers a differentiated and engaging personalized nutrition experience that addresses the aspects that influence metabolic health. Key to the success of the personalized nutrition offering is blending science-backed, data driven recommendations with behavioural change techniques, such as digital coaching, with branded products at the core of the offering. Apart from the digital platform, IFF will collaborate with brand owners to craft specialized wellness products for consumers, incorporating the company's extensive portfolio of science-backed and clinically tested ingredients, such as probiotics, prebiotics, plant proteins and fibers.